Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-002880
Filing Date
2025-08-14
Accepted
2025-08-14 07:00:21
Documents
1
Period of Report
2025-08-14

Document Format Files

Seq Description Document Type Size
1 6-K zk2533655.htm 6-K 14658
  Complete submission text file 0001178913-25-002880.txt   15646
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 251214229
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)